Search results for: “pharmaceutical companies”
-
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals)
•
Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) is an American Canadian-domiciled multinational specialty pharmaceutical company based in Laval,…
-
Vertex Pharmaceuticals to acquire Alpine Immune Sciences in $4.9 billion deal
•
Vertex Pharmaceuticals Incorporated (VRTX) has announced its plans to acquire Alpine Immune Sciences, Inc. (ALPN), a company dedicated…
-
Dr Howie McKibbon appointed CEO of Botanix Pharmaceuticals
•
SYDNEY, AUSTRALIA: Botanix Pharmaceuticals Limited (ASX: BOT), a company that specializes in clinical dermatology, has announced the promotion…
-
Launching A Safe Pharmaceutical Product: Key Things To Consider
•
The pharmaceutical industry operates at the intersection of innovation and patient welfare. While introducing new medical solutions into…
-
Should You Consider A Career In The Pharmaceutical Sector?
•
Are you considering a career in the pharmaceutical industry? Maybe you’re someone looking for a job that has…
-
Telix Pharmaceuticals acquires Optimal Tracers
•
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire…
-
How Large Is The Biopharmaceutical Industry?
•
The biopharmaceutical industry’s business models are anticipated to be altered during the next two decades by five forces,…
-
AstraZeneca signs multi-billion dollar deal with Ionis Pharmaceuticals
•
LONDON, UK: AstraZeneca has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as…
-
Hikma Pharmaceutical agrees to buy Custopharm for $375 million
•
Hikma Pharmaceutical , Custopharm , acquire, Waster Street Healthcare Partners, LONDON, UK: Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company…
-
Clinigen Group partners with Eyevance Pharmaceuticals
•
LONDON, UK: Clinigen Group plc has signed an exclusive agreement to partner with Eyevance Pharmaceuticals, a wholly-owned subsidiary…
-
Drug companies fines £260 million for competition law breaches
•
LONDON, UK: Competition and Markets Authority (CMA) has imposed fines totalling over £260 million for competition law breaches…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.